Study on the Effects of Intravenous Dexmedetomidine on Pain in Patients Undergoing Elective Spinal Surgery
Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, prospective, double-blind , placebo-controlled trial examining the
effects of intraoperative dexmedetomidine infusion on pain in patients undergoing lumbar
spinal fusion surgery. One hundred ten subjects (55 in each arm) will be enrolled. Subjects,
over the age of 18, undergoing lumbar spinal fusion will be considered eligible for
enrollment. Subjects will receive either intraoperative dexmedetomidine or placebo of normal
saline infusion. They will be followed for approximately six weeks postoperatively.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health